Trial Profile
A phase I trial of effect of siltuximab on muscle mass in patients with multicentric Castleman's disease.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Jul 2023
Price :
$35
*
At a glance
- Drugs Siltuximab (Primary)
- Indications Giant lymph node hyperplasia
- Focus Pharmacodynamics
- 06 Jun 2023 Results presented at the 59th Annual Meeting of the American Society of Clinical Oncology
- 01 Aug 2014 New trial record